CD4 and COVID-19: The reduced CD4 T‐cell Th1 responses to SARS‐CoV‐2 peptide‐challenge in individuals recovered from mild COVID‐19 under the age of 40 raises questions regarding the long‐term protective immunity that natural infection imbues in the young.